首页> 外文OA文献 >Crystal engineering of ibuprofen using starch derivatives in crystallization medium to produce promising ibuprofen with improved pharmaceutical performance
【2h】

Crystal engineering of ibuprofen using starch derivatives in crystallization medium to produce promising ibuprofen with improved pharmaceutical performance

机译:布洛芬的晶体工程在结晶介质中使用淀粉衍生物生产具有改善的药物性能的有前景的布洛芬

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Ibuprofen exhibits poor flow, poor compaction and dissolution behaviour, and it is prone to capping after ejection from the die. Therefore, the aim of the present research was to engineer ibuprofen crystals in the presence of two disintegrants (starch and sodium starch glycolate) in order to improve its flow, compactibility and dissolution behaviour simultaneously. To this end ibuprofen and different concentrations of disintegrant (0.25 to 10% w/w in case of starch and 0.25 to 7% w/w in case of sodium starch glycolate) were dissolved in ethanol and water respectively. The ibuprofen solution was then added to the aqueous solutions containing the different concentrations of disintegrant. Ibuprofen precipitated within 10 min and the crystals were separated and dried for further studies. The obtained crystals were characterized in terms of flow, density, tablet hardness, dissolution behaviour and solid state. The results showed most of engineered ibuprofen to have better flow with a high compactibility. The results also showed that an increase in the concentration of starch in the crystallization medium resulted in a reduction in the hardness of ibuprofen tablets, but this was not the case for ibuprofen samples engineered in the presence of sodium starch glycolate. It is interesting to note that although engineered ibuprofen showed superior dissolution as compared to untreated ibuprofen, the highest concentration of starch (10%) or sodium starch glycolate (7%) slowed down the release remarkably due to an increase in the viscosity of the dissolution medium around drug particles. Solid state analysis (FT-IR, XRPD and DSC) ruled out the presence of different polymorphic forms and also any interaction between these disintegrants and ibuprofen. In conclusion, the engineering of ibuprofen in the presence of disintegrant showed how properties such as flow, compaction and dissolution behaviour can be simultaneously manipulated to suit a desired application.
机译:布洛芬显示出差的流动性,差的压实性和溶解性,并且从模具中弹出后容易发生压盖。因此,本研究的目的是在两种崩解剂(淀粉和淀粉羟乙酸钠)存在下对布洛芬晶体进行工程设计,以同时改善其流动性,致密性和溶解行为。为此,将布洛芬和不同浓度的崩解剂(对于淀粉而言为0.25至10%w / w,对于羟乙酸淀粉钠而言为0.25至7%w / w)分别溶解在乙醇和水中。然后将布洛芬溶液加入到含有不同浓度崩解剂的水溶液中。布洛芬在10分钟内沉淀,分离出晶体并干燥以进行进一步研究。根据流动性,密度,片剂硬度,溶解行为和固态表征了获得的晶体。结果表明,大多数工程布洛芬具有更好的流动性和较高的压实性。结果还表明,结晶介质中淀粉浓度的增加导致布洛芬片剂的硬度降低,但是在乙醇酸淀粉钠存在下进行工程处理的布洛芬样品并非如此。有趣的是,尽管与未处理的布洛芬相比,工程布洛芬显示出更好的溶出度,但由于溶出度增加,最高浓度的淀粉(10%)或淀粉羟乙酸钠(7%)显着减慢了释放速度。药物颗粒周围的培养基。固态分析(FT-IR,XRPD和DSC)排除了不同多晶型物的存在以及这些崩解剂与布洛芬之间的任何相互作用。总之,布洛芬在崩解剂存在下的工程设计表明,如何同时控制流动性,致密性和溶解行为等特性以适应所需的应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号